BioCentury
ARTICLE | Clinical News

Plumiaz diazepam nasal spray regulatory update

May 5, 2014 7:00 AM UTC

FDA issued a complete response letter for Acorda's Plumiaz diazepam nasal spray to treat acute repetitive seizures in epileptics. The biotech said FDA asked for an additional clinical trial, but decli...